etanautine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
4534 6888-11-5

Description:

MoleculeDescription

Synonyms:

  • etanautine
  • bietanautine
  • nautamine
  • Molecular weight: 493.56
  • Formula: C26H31N5O5
  • CLOGP: 1.87
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 12.47
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC N04AB01 NERVOUS SYSTEM
ANTI-PARKINSON DRUGS
ANTICHOLINERGIC AGENTS
Ethers chemically close to antihistamines
CHEBI has role CHEBI:48407 antiparkinson drug

Related Drugs by ATC class:

N04AB Ethers chemically close to antihistamines 1 drug

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
857401-00-4 SECONDARY_CAS_RN
CHEBI:755730 CHEBI
CHEMBL3707215 ChEMBL_ID
DB13636 DRUGBANK_ID
97H5S09M4T UNII
C3652696 UMLSCUI
10255142 PUBCHEM_CID
97H5S09M4T INXIGHT DRUGS

Pharmaceutical products:

None